205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
17.22%
Revenue growth 1.25-1.5x ON's 12.65%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
31.76%
Gross profit growth 1.25-1.5x ON's 27.21%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
80.61%
EBIT growth below 50% of ON's 262.77%. Michael Burry would suspect deeper competitive or cost structure issues.
122.45%
Operating income growth under 50% of ON's 262.77%. Michael Burry would be concerned about deeper cost or sales issues.
106.92%
Net income growth under 50% of ON's 1096.67%. Michael Burry would suspect the firm is falling well behind a key competitor.
104.76%
EPS growth under 50% of ON's 1085.92%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
110.00%
Diluted EPS growth under 50% of ON's 1085.92%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.95%
Share reduction while ON is at 0.62%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.31%
Reduced diluted shares while ON is at 4.37%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.23%
Dividend growth of 0.23% while ON is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
49.73%
Similar OCF growth to ON's 50.26%. Walter Schloss would assume comparable operations or industry factors.
19.45%
FCF growth under 50% of ON's 75.69%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
61.72%
Positive 10Y revenue/share CAGR while ON is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
22.16%
Positive 5Y CAGR while ON is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-8.11%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
110.74%
Positive long-term OCF/share growth while ON is negative. John Neff would see a structural advantage in sustained cash generation.
22.04%
Below 50% of ON's 72.27%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
138.85%
Positive 3Y OCF/share CAGR while ON is negative. John Neff might see a big short-term edge in operational efficiency.
79.23%
Positive 10Y CAGR while ON is negative. John Neff might see a substantial advantage in bottom-line trajectory.
31.73%
5Y net income/share CAGR similar to ON's 29.96%. Walter Schloss might see both on parallel mid-term trajectories.
-8.03%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
59.53%
10Y equity/share CAGR above 1.5x ON's 16.48%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
0.89%
Below 50% of ON's 219.95%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-5.83%
Negative 3Y equity/share growth while ON is at 3519.15%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
460.05%
Dividend/share CAGR of 460.05% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
428.42%
Dividend/share CAGR of 428.42% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
260.00%
Our short-term dividend growth is positive while ON cut theirs. John Neff views it as a comparative advantage in shareholder returns.
15.35%
AR growth well above ON's 4.17%. Michael Burry fears inflated revenue or higher default risk in the near future.
4.99%
We show growth while ON is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
3.41%
Asset growth above 1.5x ON's 2.27%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.42%
50-75% of ON's 5.69%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-0.27%
Our R&D shrinks while ON invests at 6.11%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
3.98%
We expand SG&A while ON cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.